Themis Medicare Limited (NSE:THEMISMED)
India
· Delayed Price · Currency is INR 129.20
-2.47 (-1.88%)
Jun 27, 2025, 3:29 PM IST
Themis Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 4,055 | 3,818 | 3,543 | 3,946 | 2,307 | Upgrade
| |
Revenue Growth (YoY) | 6.22% | 7.74% | -10.21% | 71.07% | 14.43% | Upgrade
|
Cost of Revenue | 1,320 | 1,389 | 1,209 | 1,509 | 801.35 | Upgrade
|
Gross Profit | 2,735 | 2,429 | 2,334 | 2,437 | 1,505 | Upgrade
|
Selling, General & Admin | 963.76 | 997.86 | 781.03 | 610.08 | 443.62 | Upgrade
|
Other Operating Expenses | 1,281 | 915.99 | 878.76 | 870.91 | 566.8 | Upgrade
|
Operating Expenses | 2,344 | 2,036 | 1,765 | 1,576 | 1,096 | Upgrade
|
Operating Income | 391.2 | 392.59 | 569.56 | 861.55 | 409.46 | Upgrade
|
Interest Expense | -100.4 | -76.28 | -79.9 | -65.37 | -109.66 | Upgrade
|
Interest & Investment Income | - | 24.45 | 47.52 | 37.19 | 23.4 | Upgrade
|
Earnings From Equity Investments | 59.25 | 188.05 | 136.18 | 113.4 | 94.75 | Upgrade
|
Currency Exchange Gain (Loss) | - | 16.72 | 32.27 | 15.24 | 5.81 | Upgrade
|
Other Non Operating Income (Expenses) | 46.7 | -11.11 | 19.51 | -9.39 | -10.46 | Upgrade
|
Pretax Income | 396.75 | 534.43 | 725.15 | 952.62 | 413.31 | Upgrade
|
Income Tax Expense | 98.42 | 99.2 | 156.14 | 223.81 | 56.28 | Upgrade
|
Earnings From Continuing Operations | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade
|
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Net Income | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade
|
Net Income to Common | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade
|
Net Income Growth | -31.46% | -23.51% | -21.93% | 104.13% | 44.07% | Upgrade
|
Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | Upgrade
|
Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | Upgrade
|
Shares Change (YoY) | -0.14% | 0.03% | 0.01% | 0.28% | 0.04% | Upgrade
|
EPS (Basic) | 3.24 | 4.73 | 6.18 | 7.92 | 3.89 | Upgrade
|
EPS (Diluted) | 3.24 | 4.72 | 6.17 | 7.91 | 3.88 | Upgrade
|
EPS Growth | -31.36% | -23.50% | -21.97% | 103.58% | 44.01% | Upgrade
|
Free Cash Flow | 192.84 | 36.76 | -126.55 | 137.67 | 389.36 | Upgrade
|
Free Cash Flow Per Share | 2.09 | 0.40 | -1.37 | 1.49 | 4.24 | Upgrade
|
Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.500 | 0.430 | Upgrade
|
Dividend Growth | - | - | - | 16.28% | 145.71% | Upgrade
|
Gross Margin | 67.45% | 63.62% | 65.88% | 61.77% | 65.26% | Upgrade
|
Operating Margin | 9.65% | 10.28% | 16.07% | 21.83% | 17.75% | Upgrade
|
Profit Margin | 7.36% | 11.40% | 16.06% | 18.47% | 15.48% | Upgrade
|
Free Cash Flow Margin | 4.75% | 0.96% | -3.57% | 3.49% | 16.88% | Upgrade
|
EBITDA | 490.48 | 510.5 | 666.88 | 947.1 | 488.82 | Upgrade
|
EBITDA Margin | 12.10% | 13.37% | 18.82% | 24.00% | 21.19% | Upgrade
|
D&A For EBITDA | 99.29 | 117.91 | 97.32 | 85.55 | 79.35 | Upgrade
|
EBIT | 391.2 | 392.59 | 569.56 | 861.55 | 409.46 | Upgrade
|
EBIT Margin | 9.65% | 10.28% | 16.07% | 21.83% | 17.75% | Upgrade
|
Effective Tax Rate | 24.81% | 18.56% | 21.53% | 23.49% | 13.62% | Upgrade
|
Revenue as Reported | 4,102 | 3,865 | 3,658 | 4,012 | 2,343 | Upgrade
|
Advertising Expenses | - | 152.07 | 101.5 | 80.56 | 35.38 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.